HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

alemtuzumab (Campath)

a therapeutic antibody directed against the CDw52 antigen expressed by the lymphocytes and has proven lytic abilities both in vitro & in vivo; has been sequenced; do not confuse with Campath-1H antigen
Also Known As:
Campath; Campath 1H; Berlex brand of alemtuzumab; Campath-1H; MabCambath; MedacSchering brand of alemtuzumab; Schering brand of alemtuzumab; monoclonal antibody Campath-1H
Networked: 983 relevant articles (148 outcomes, 176 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Coles, Alasdair J: 21 articles (12/2014 - 01/2006)
2. Mackinnon, Stephen: 19 articles (01/2015 - 02/2002)
3. Hale, Geoff: 17 articles (03/2015 - 02/2002)
4. Osterborg, Anders: 14 articles (11/2011 - 01/2002)
5. Keating, Michael J: 14 articles (08/2011 - 05/2002)
6. Pagliuca, Antonio: 13 articles (03/2015 - 09/2002)
7. Mufti, Ghulam J: 13 articles (07/2014 - 09/2002)
8. Hallek, Michael: 13 articles (08/2013 - 01/2002)
9. Faderl, Stefan: 13 articles (06/2013 - 08/2003)
10. O'Brien, Susan: 13 articles (08/2011 - 01/2004)

Related Diseases

1. B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
2. Relapsing-Remitting Multiple Sclerosis
3. Graft vs Host Disease (Graft-Versus-Host Disease)
4. Multiple Sclerosis
5. Infection

Related Drugs and Biologics

1. fludarabine
2. rituximab (Mabthera)
3. alemtuzumab (Campath)
4. Interferons
5. Monoclonal Antibodies
6. Cyclophosphamide (Cytoxan)
7. interferon beta 1a
8. natalizumab (Tysabri)
9. daclizumab (dacliximab)
10. ofatumumab

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Stem Cell Transplantation
3. Transplants (Transplant)
4. Transplantation (Transplant Recipients)
5. Hematopoietic Stem Cell Transplantation